With Phase III Success, PharmaEssentia To Seek Besremi Label Expansion (Update)

 
• By Joseph Haas
  
PharmaEssentia wants to add a second platelet disorder to the Besremi label (Shutterstock)

More from Clinical Trials

More from Therapy Areas